Zomedica Pharmaceuticals 

C$0.1
880
-C$0-0.21% Tuesday 14:50

Statistics

Day High
0.1
Day Low
0.09
52W High
0.2
52W Low
0.02
Volume
790,936
Avg. Volume
8,541,418
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

4MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.07
-0.05
-0.02
0
Expected EPS
-0.01244835
Actual EPS
N/A

Financials

-171.16%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
37.66MRevenue
-64.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ZOM. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.
Show more...
CEO
Mr. Larry C. Heaton II
Employees
144
Country
US

Listings

0 Comments

Share your thoughts

FAQ

What is Zomedica Pharmaceuticals stock price today?
The current price of ZOM is C$0.1 CAD — it has decreased by -0.21% in the past 24 hours. Watch Zomedica Pharmaceuticals stock price performance more closely on the chart.
What is Zomedica Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Zomedica Pharmaceuticals stocks are traded under the ticker ZOM.
What is Zomedica Pharmaceuticals revenue for the last year?
Zomedica Pharmaceuticals revenue for the last year amounts to 37.66M CAD.
What is Zomedica Pharmaceuticals net income for the last year?
ZOM net income for the last year is -64.47M CAD.
How many employees does Zomedica Pharmaceuticals have?
As of April 04, 2026, the company has 144 employees.
In which sector is Zomedica Pharmaceuticals located?
Zomedica Pharmaceuticals operates in the Health Care sector.
When did Zomedica Pharmaceuticals complete a stock split?
Zomedica Pharmaceuticals has not had any recent stock splits.
Where is Zomedica Pharmaceuticals headquartered?
Zomedica Pharmaceuticals is headquartered in Ann Arbor, US.